DalsnaFinance › IPOs › Latigo Biotherapeutics, Inc. › IPO
Latigo Biotherapeutics, Inc. completed its initial public offering on Nasdaq on August 4, 2026, pricing at $18.00 a share.
| Ticker | LTGO |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | August 4, 2026 |
| Offering price | $18.00 |
| Shares offered | 19,200,000 |
| Total raised | $346M |
| Sector | Pharmaceutical Preparations |
Latigo Biotherapeutics, Inc. listed on Nasdaq on 2026-08-04.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 2056611.
Latigo Biotherapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Latigo Biotherapeutics, Inc.. This page is general information, not investment advice.